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chapter, Markert defines neoplasias as
"diseases of cell differentiation stemming
from a mis-programming of normal gene
function. This mis-programming can have
many causes, but all cancer must act by
changing the function of regulatory DNA".
While he accepts this to be a dogmatic state-
ment, and critically examines its implications
in the subsequient discussion, it delineates
very wi-ell thethemefor themeeting. Particular
aspects are then enlarged upoIn by individual
authors.
Mintz reviews her work on genetic mosai-
cism, and the exciting implications that
normalization of teratocarcinoma cells in
mosaic embrvos has fortheunderstanding and
possible control of neoplastic growth. Pierce
and Cox emphasize that not all tumour cells
are equal, and that it is the undifferentiated
proliferating community that poses the threat
to the host, not the terminally differentiated
component wrhich forms the bulk of many
tumours.
That a genetic disturbance underlies
oncogenesis for many human tumours, in
particular those of the nervous system, is
emphasized by Knudson and Meadows,
Hermani and VandenBerg, and Prasad and
Sinha, and the implications of genetic dis-
turbance in terms ofaltered differentiation are
considered by several authors. However,
the symposium organizers managed to avoid
the usual catalogue of changes in phenotype,
all claimed to be markers of neoplastic
transformation by their individual devotees.
Instead attention was focused on the mole-
cular mechanisms underlying gene expres-
sion, both in the normal developing organism
and in the development of cancer. One of
the best models for investigating the inter-
relationship of differentiation and prolifera-
tion is normal haemopoiesis, starting from
the pluripotential stem cell, as discussed
by Lajtha and his collaborators in England
and by Iscove from Swritzerland. The regula-
tion of haemopoiesis and the disturbances
of differentiation leading to leukaemias are
the subject of several excellent papers in this
section on haemopoietic stem-cell systems.
The expression ofalpha-foetoprotein during
both ontogenesis and oncogensis is reviewed
by Abelev. Specific gene functions and control
of gene transciption and translation in both
eukaryotic and prokaryotic cells are covered
by 7 other papers in the section on molecular
mechanisms of gene expression, and methods
of investigating aberrations in the control of
gene expression are considered in the sub-
sequent section. A particularly interesting
model is described by Gurdon and his co-
workers which involves the injection of
purified DNA with characterized transcrip-
tion products into the nucleii of living
oocytes, and its use to identify and char-
acterize gene-controlling molecules from living
cells. In the final section, Marks and his
colleagues consider pathways by which
exogenous agents can affect the cell and
induce normal erythropoietic differentiation
in murine erythrolukaemia cells. O'Malley
and co-workers provide evidence that non-
histone proteins can regulate the expression
of the gene coding for ovalbumin in chick
oviducts. A thoughtful and comprehensive
paper by Rutter et al. describes the use of
the pancreas as an analytical tool for investi-
gating the regulatory mechanisms controlling
normal organogenesis.Theydelineate3phases,
or differentiative transitions, in the develop-
ment of the exocrine pancreas, involving
first, morphogenesis and specific gene
expression, second, overt cytodifferentiation
and synthesis of pancreas-specific gene pro-
ducts and third, the selective modulation of
gene expression in the mature organ. They
also raise the possibility of distinguishing
oncogenic target cells in terms of their
position of this scale of progressive differen-
tiation.
Overall, the papers in this volume present
good evidence that cancer is essentially a
disturbance of cell differentiation and that
the process is not necessarily irreversible. It is
a book which will interest not only individuals
involved in cancer research, but also chemists,
molecular biologists, cell biologists and
geneticists. Many of the papers are provo-
cative and stimulating; few are dull, and
between them they provide a very useful
and comprehensive bibliography.
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This book documents the proceedings of
a workshop on Tumour Markers and was
organized under the auspices of the Dutch
Scientific Council on Cancer Research.1006 BOOK REVIEWS
It consists of 3 sections: firstly a review of
markers, secondly fundamental aspects of
markers, and the last chapter is concerned
with the clinical implications of markers. In
general the review of various markers is
fairly comprehensive, though no considera-
tion is given to the clinical situations such
as medullary thyroid carcinoma and chorio-
carcinoma where the value of markers has
been greatest. The first review, by Ratcliffe,
discusses the ectopic hormones; the value of
hormonal markers in non-endocrine tumours
has always been in doubt and this chapter
confirms this view. Even the best docu-
mented association, that of adrenocortico-
trophic hormone with lung carcinoma seems
to have little clinical application at present.
The role of peptide hormone receptors in
common cancers, particularly breast and
gastrointestinal tumours, is clearly an area
for future research. In addition, the appli-
cation of radioimmunoassays using antisera
to high-rnolecular-weight components of
hormones produced by tumours may well
have clinical value.
Two further markers considered are Acid
Phosphatase by Chu and Polvamines by
Russell. The chapter by Chu makes the
interesting observation that isoelectric focus-
ing of prostatic acid phosphatase indicates
that this may be unique, and clearly more
specific radioimmunoassays than the one
mentioned can now be developed. The poly-
amines have been disappointing as markers
for the common solid tumours, but their
application in predicting response to chemo-
therapy is being explored. In particular their
value in some experimental breast carcinoma
models show that the acute release of poly-
amines indicates therapeutic success.
One of the more interesting aspects of the
volume is the concept of the application of
antisera to tumour markers in the localization
of tumours. Ceriani and Goldenberg have
described their results using antisera against
mammary epithelial antigens and carcino-
embryonic antigen respectively. Preliminary
results with 1251-labelled antibodies against
mammary epithelial antigens indicate locali-
zation in experimental animals. Labelled
antisera to CEA have been used now in a
large number of patients studied by Golden-
berg and seem to be of some value, in CEA-
producing tumours and provided the locali-
zation of deposits in brain and bone is not
desired. A further new application of markers
wvas outlined by Mach, who advocated the
follow-up at 3-monthly intervals with CEA
measurements of colorectal cancer, with
second-look surgery should the levels of this
antigen rise. He also feels that CEA may
have value as an index of therapeutic
effectiveness in other tumours, though the
data for this do not yet exist.
The novel approach of Kohler and Mill-
stein of raising monoclonal antibodies to
selected antigens is discussed with reference to
human leukaemias by Bernie et al. of the
Beatson Institute, and clearly monoclonal
antibodies may well be of value in tumour
localization by the methods already out-
lined by Goldenberg and Ceriani. An interest-
ing chapter by Burger et al. discusses the
evidence for the cell surface influencing
metastasis, and these workers describe studies
with B16 melanoma cells in which lectin-
resistant cells had little metastatic capacity.
Cell-surface-labelling techniques were applied
to the high and low metastatic cell lines, and
clearly monoclonal antisera raised against
these components could have application in
imaging and diagnosis. These workers con-
firmed the work of Fidler by obtaining cells
with apparently unique capacity to meta-
stasize to the liver. There is an unfortunate
lack of discussion following this chapter,
in spite of the importance of these claims.
Various reviews are included inthis volume,
particularly on the place of tumour markers
in bladder, ovarian and testicular cancer,
and the situation in human breast cancer is
reviewed by Neville and Heyderman. These
chapters all indicate that much more basic
work is needed before a satisfactory clinically
useful marker will be found for these tumours.
In conclusion, most of the more recent
approaches to tumour localization are
covered, and this volume should provide
an important reference for both scientists
and oncologists.
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More than half the world's population now!
lives in countries where cancer is among the
top-ranking causes of death. A rough WHO
estimate suggests that by the year 2000 the
number of cancer deaths may rise bv more
than 50%o to about 8 million annually, and